It has also been reported that loss of DAL-1 expression and methylation of the DAL-1 promoter are involved in development and progression of NSCLC (Non small cell carcinoma), providing a possible indicator of poor prognosis. This evidence concerns the gene EPB41L3 and non-small cell lung carcinoma.